Boston Scientific's Strong Japanese Sales Help Offset U.S., EU Declines
This article was originally published in The Gray Sheet
Executive Summary
Emerging stent and balloon markets in Japan gave Boston Scientific its fourth consecutive quarter of market leadership in those businesses, as revenues grew 47% over the fourth quarter of 1998, the firm reported during a Feb. 8 teleconference.